Get the Stockscreener App
5.31
8.27%
-0.46
Genprex Inc stock is traded at $5.31, with a volume of 145.27K.
It is down -8.27% in the last 24 hours and down -44.84% over the past month.
Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.
See More
Previous Close:
$5.77
Open:
$5.37
24h Volume:
145.27K
Relative Volume:
0.21
Market Cap:
$5.80M
Revenue:
-
Net Income/Loss:
$-22.71M
P/E Ratio:
-0.4535
EPS:
-11.71
Net Cash Flow:
$-18.24M
1W Performance:
-39.51%
1M Performance:
-44.84%
6M Performance:
-63.50%
1Y Performance:
-95.08%
1-Day Range:
$5.22
$5.78
1-Week Range:
$5.22
$9.8908
52-Week Range:
$5.22
$117.50
Genprex Inc Stock (GNPX) Company Profile
Name
Genprex Inc
Sector
Industry
Phone
512-537-7997
Address
1601 TRINITY STREET, BLDG. B, AUSTIN, TX
Compare GNPX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GNPX
Genprex Inc
|
5.31 | 5.80M | 0 | -22.71M | -18.24M | -11.71 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.63 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.39 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.26 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
821.78 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
183.80 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Genprex Inc Stock (GNPX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-26-21 | Initiated | National Securities | Buy |
| Apr-29-19 | Initiated | Noble Capital Markets | Outperform |
Genprex Inc Stock (GNPX) Latest News
What technical models suggest about Genprex Inc.’s comeback2025 Winners & Losers & Detailed Earnings Play Strategies - newser.com
How Genprex Inc. stock responds to policy changes2025 Big Picture & Low Risk Entry Point Tips - newser.com
Is Genprex Inc. stock safe for conservative investorsWeekly Earnings Recap & Low Drawdown Momentum Ideas - newser.com
Why Genprex Inc. stock is popular among millennialsMarket Weekly Review & Long-Term Safe Investment Plans - newser.com
Can Genprex Inc. (2DE0) stock reach $200 price targetEarnings Miss & Short-Term High Return Strategies - newser.com
How to integrate Genprex Inc. into portfolio analysis toolsPortfolio Update Report & Verified Chart Pattern Signals - newser.com
What indicators show strength in Genprex Inc.2025 Market Overview & Daily Risk Controlled Trade Plans - newser.com
Can Genprex Inc. (2DE0) stock sustain margin levels2025 Analyst Calls & Growth Focused Entry Reports - newser.com
Genprex Inc. stock retracement – recovery analysisWeekly Loss Report & Risk Managed Investment Strategies - newser.com
Tools to monitor Genprex Inc. recovery probability2025 Volatility Report & Safe Capital Preservation Plans - newser.com
Backtesting results for Genprex Inc. trading strategiesWeekly Stock Analysis & Short-Term Trading Alerts - newser.com
Can Genprex Inc. (2DE0) stock stage a strong rebound this quarterJuly 2025 Catalysts & Advanced Technical Signal Analysis - newser.com
Will Genprex Inc. stock deliver consistent dividends2025 Big Picture & High Win Rate Trade Alerts - newser.com
Will Genprex Inc. stock reach Wall Street targetsEarnings Overview Summary & AI Enhanced Trade Execution Alerts - newser.com
Is Genprex Inc. stock ready for a breakout2025 Price Targets & Fast Entry High Yield Stock Tips - newser.com
Can technical indicators confirm Genprex Inc.’s reversalQuarterly Portfolio Summary & Daily Stock Trend Watchlist - newser.com
How institutional ownership impacts Genprex Inc. stockJuly 2025 Catalysts & Free High Accuracy Swing Entry Alerts - newser.com
How Genprex Inc. (2DE0) stock reacts to Fed tightening2025 Geopolitical Influence & Daily Risk Controlled Trade Plans - newser.com
Why analysts recommend Genprex Inc. (2DE0) stockJuly 2025 Patterns & Reliable Momentum Entry Alerts - newser.com
Why OUTFRONT Media Inc. stock attracts strong analyst attention - newser.com
Genprex Inc Stock (GNPX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.29%
0.16%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):